Christopher Robinson, a regenerative medicine and pain physician at the Johns Hopkins University School of Medicine, told Undark that hes applying for funding to run clinical trials testing BPC-157 and other peptides as treatments for chronic pain
Some people notice subtle shifts, perhaps slightly easier sleep onset or marginally improved morning alertness, but many notice nothing at all
Insurance services for the cost of medications are provided through the LifeMD GLP-1 weight loss programs
While these results cannot be directly extrapolated to human pulmonary hypertension patients, they suggest BPC-157 may influence the vascular remodeling processes that underlie this condition
Nguyen DB, Wagner-Britz L, Maia S, Steffen P, Wagner C, Kaestner L, et al